Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity (Unaudited)

v3.19.1
Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Equity Payable
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance, Amount at Dec. 31, 2017 $ 37,025 $ 100,862 $ 77,910,842 $ (65,764) $ (80,619,483) $ (2,636,518)
Beginning balance, Shares at Dec. 31, 2017 37,025,140          
Issuance of common stock for cash, Amount $ 5,775 5,769,225 5,775,000
Issuance of common stock for cash, Shares 5,775,000          
Issuance of common stock for warrant conversion, Amount $ 2,103 2,253,359 2,255,462
Issuance of common stock for warrant conversion, Shares 2,102,804          
Issuance of common stock for debt conversion, Amount $ 1,047 1,088,439 1,089,486
Issuance of common stock for debt conversion, Shares 1,047,583          
Issuance of common stock for cashless warrant conversion, Amount $ 10 (10)
Issuance of common stock for cashless warrant conversion, Shares 10,234          
Issuance of common stock for options exercised, Amount $ 37 21,458 21,495
Issuance of common stock for options exercised, Shares 37,292          
Stock based compensation 965,161 965,161
Foreign currency translation adjustment 70,523 70,523
Net loss (7,215,648) (7,215,648)
Ending balance, Amount at Dec. 31, 2018 $ 45,998 100,862 88,008,473 4,759 (87,835,132) 324,960
Ending balance, Shares at Dec. 31, 2018 45,998,053          
Stock based compensation 180,749 180,749
Foreign currency translation adjustment (28,449) (28,449)
Net loss (1,821,647) (1,821,647)
Ending balance, Amount at Mar. 31, 2019 $ 45,998 $ 100,862 $ 88,189,222 $ (23,690) $ (89,656,779) $ (1,344,387)
Ending balance, Shares at Mar. 31, 2019 45,998,053